Pfizer Gets a Dose of their Own Medicine from Moderna…Legally.

Juhi Desai

Associate Editor

Loyola University Chicago School of Law, JD 2024

As if the world has not had enough of its fair share of COVID-19-related matters, news regarding the virus has topped headlines once again. On August 26, 2022, Moderna, a pharmaceutical and biotechnology company, publicly announced it was filing two patent-infringement lawsuits against its rival, Pfizer, Inc., and its development partner, BioNTech. Moderna claims Pfizer duplicated its vaccine technology that was later used to administer doses to help combat the COVID-19 virus. This suit comes nearly two years after the Food Drug Administration (FDA) permitted both pharmaceuticals to roll out the first vaccine against COVID-19.

Continue reading